These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23305315)

  • 1. pH-triggered nanoparticle mediated delivery of siRNA to liver cells in vitro and in vivo.
    Kolli S; Wong SP; Harbottle R; Johnston B; Thanou M; Miller AD
    Bioconjug Chem; 2013 Mar; 24(3):314-32. PubMed ID: 23305315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles.
    Carmona S; Jorgensen MR; Kolli S; Crowther C; Salazar FH; Marion PL; Fujino M; Natori Y; Thanou M; Arbuthnot P; Miller AD
    Mol Pharm; 2009; 6(3):706-17. PubMed ID: 19159285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
    Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
    Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
    Wang XL; Xu R; Lu ZR
    J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
    Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
    Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-labile PEGylation of siRNA-loaded lipid nanoparticle improves active targeting and gene silencing activity in hepatocytes.
    Hashiba K; Sato Y; Harashima H
    J Control Release; 2017 Sep; 262():239-246. PubMed ID: 28774839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
    Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
    Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEGylated cyclodextrins as novel siRNA nanosystems: correlations between polyethylene glycol length and nanoparticle stability.
    Godinho BM; Ogier JR; Quinlan A; Darcy R; Griffin BT; Cryan JF; O'Driscoll CM
    Int J Pharm; 2014 Oct; 473(1-2):105-12. PubMed ID: 24992319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of an in vitro assay to screen lipid based nanoparticles for siRNA delivery.
    Zhang Y; Arrington L; Boardman D; Davis J; Xu Y; DiFelice K; Stirdivant S; Wang W; Budzik B; Bawiec J; Deng J; Beutner G; Seifried D; Stanton M; Gindy M; Leone A
    J Control Release; 2014 Jan; 174():7-14. PubMed ID: 24240015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doping hydroxylated cationic lipid into PEGylated cerasome boosts in vivo siRNA transfection efficacy.
    Li Y; Zheng S; Liang X; Jin Y; Wu Y; Bai H; Liu R; Dai Z; Liang Z; Shi T
    Bioconjug Chem; 2014 Nov; 25(11):2055-66. PubMed ID: 25260060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylgalactosamine functionalized mixed micellar nanoparticles for targeted delivery of siRNA to liver.
    Wang HX; Xiong MH; Wang YC; Zhu J; Wang J
    J Control Release; 2013 Mar; 166(2):106-14. PubMed ID: 23266452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
    Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient siRNA delivery to mammalian cells using layered double hydroxide nanoparticles.
    Ladewig K; Niebert M; Xu ZP; Gray PP; Lu GQ
    Biomaterials; 2010 Mar; 31(7):1821-9. PubMed ID: 19922997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
    Dong DW; Xiang B; Gao W; Yang ZZ; Li JQ; Qi XR
    Biomaterials; 2013 Jul; 34(20):4849-59. PubMed ID: 23541420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA.
    Heidel JD; Yu Z; Liu JY; Rele SM; Liang Y; Zeidan RK; Kornbrust DJ; Davis ME
    Proc Natl Acad Sci U S A; 2007 Apr; 104(14):5715-21. PubMed ID: 17379663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme-triggered PEGylated pDNA-nanoparticles for controlled release of pDNA in tumors.
    Yingyuad P; Mével M; Prata C; Furegati S; Kontogiorgis C; Thanou M; Miller AD
    Bioconjug Chem; 2013 Mar; 24(3):343-62. PubMed ID: 23305338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo.
    Hatakeyama H; Ito E; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
    J Control Release; 2009 Oct; 139(2):127-32. PubMed ID: 19540888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi).
    Pan Q; Ramakrishnaiah V; Henry S; Fouraschen S; de Ruiter PE; Kwekkeboom J; Tilanus HW; Janssen HL; van der Laan LJ
    Gut; 2012 Sep; 61(9):1330-9. PubMed ID: 22198713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural contributions of blocked or grafted poly(2-dimethylaminoethyl methacrylate) on PEGylated polycaprolactone nanoparticles in siRNA delivery.
    Lin D; Huang Y; Jiang Q; Zhang W; Yue X; Guo S; Xiao P; Du Q; Xing J; Deng L; Liang Z; Dong A
    Biomaterials; 2011 Nov; 32(33):8730-42. PubMed ID: 21885115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.